Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers

European Journal of Cancer

Volumn 35, Issue 8, 1999, Pages 1248-1257

  Johannsson, O ^b   Loman, N ^b   Moller T ^b   Kristoffersson, U ^a   Borg, Å ^b   Olsson, H ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

BRCA1; BRCA2; Breast cancer; Cancer incidence; Hereditary cancer; Male breast cancer; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; FAMILIAL CANCER; FAMILY; FEMALE; HUMAN; MALE; MUTATION; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; RELATIVE; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; SWEDEN;

ADULT; AGED; BRCA2 PROTEIN; FAMILY; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS; PEDIGREE; RETROSPECTIVE STUDIES; SWEDEN; TRANSCRIPTION FACTORS;

EID: 0032794999     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00135-5     Document Type: Article

References (23)

1. Ford D., Easton D.F., Stratton M.et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet. 62:1998;676-689.
2. Ford D., Easton D.F., Bishop D.T., Narod S.A., Goldgar D.E. Consortium BCL. Risks of cancer in BRCA1-mutation carriers. Lancet. 343:1994;692-695.
3. Arason A., Barkadóttir R.B., Egilsson V. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Iclandic families, and possible relationship to prostatic cancer. Am. J. Hum. Genet. 52:1993;711-717.
4. Burke W., Petersen G., Lynch P.et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA. 227:1997;915-919.
5. Goldgar D.E., Neuhausen S.L., Steele L.et al. A 45-year follow-up of kindred 107 and the search for BRCA2. J. Natl. Cancer Inst. Monogr. 17:1995;15-19.
6. Gudmundsson J., Johannesdottir G., Bergthorsson J.T.et al. Different tumor types from BRCA2 carriers show wild-type chromosome deletion on 13q12-q13. Cancer Res. 55:1995;4830-4832.
7. Tonin P., Ghadirian P., Phelan C.et al. A large multisitic cancer family linked to BRCA2. J. Med. Genet. 32:1995;982-984.
8. Katagiri T., Nakamura Y., Miki Y. Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res. 56:1996;4475-4557.
9. Goggins M., Schutte M., Lu J.et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56:1996;5360-5364.
10. Tonin P., Weber B., Offit K.et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature Med. 2:1996;1179-1183.
11. Thorlacius S., Olafsdottir G., Jonasson L.et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet. 13:1996;117-119.
12. Phelan C.M., Lancaster J.M., Tonin P.et al. Mutation analysis of the BRCA2 gene in 49 sitespecific breast cancer families. Nat. Genet. 13:1996;120-122.
13. Easton D.F., Steele L., Fields P.et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am. J. Hum. Genet. 61:1997;120-128.
14. Nelson N.J. BRCA1/2 carriers. J. Natl. Cancer Inst. 90:1998;189-190.
15. Easton D.F., Bishop D.T., Ford D., Crockford G.P. Consortium BCL. Genetic linkage analysis in familial breast and ovarian cancer. results from 214 families. The Breast Cancer Linkage Consortium Am. J. Hum. Genet. 52:1993;678-701.
16. Easton D.F., Ford D., Bishop D.T. Consortium BCL. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J. Hum. Genet. 56:1995;265-271.
17. Struewing J.P., Hartge P., Wacholder S.et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med. 336:1997;1401-1408.
18. Friedman L.S., Szabo C.I., Ostermeyer E.A.et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185del AG in Ashkenazi Jewish families. Am. J. Hum. Genet. 57:1995;1284-1297.
19. Stoppa-Lyonnet D., Fricker J.P., Essioux L.et al. Segregation of two BRCA1 mutations in a single family. Am. J. Hum. Genet. 59:1996;479-481.
20. Liede A., Tonin P.N., Sun C.C.et al. Is hereditary site-specific ovarian cancer a distinct genetic condition? Am. J. Med. Genet. 75:1998;55-58.
21. Haraldsson K., Loman N., Johannsson O., Olsson H., Borg Å BRCA2 germline mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res. 58:1998;1367-1371.
22. Johannsson O.T., Idvall I., Anderson C., Borg Å., Egilsson V., Olsson H. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer. 33:1997;362-371.
23. Håkansson S., Johannsson O., Johansson U.et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutation in Scandinavian familial breast cancer. Am. J. Hum. Genet. 60:1997;1068-1078.